{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T00:17:29Z","timestamp":1791073049488,"version":"4.1.0"},"reference-count":183,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2009,10,1]],"date-time":"2009-10-01T00:00:00Z","timestamp":1254355200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biochimica et Biophysica Acta (BBA) - General Subjects"],"published-print":{"date-parts":[[2009,10]]},"DOI":"10.1016\/j.bbagen.2009.07.016","type":"journal-article","created":{"date-parts":[[2009,7,25]],"date-time":"2009-07-25T13:39:04Z","timestamp":1248529144000},"page":"1124-1132","source":"Crossref","is-referenced-by-count":82,"title":["The unsolved relationship of brain aging and late-onset Alzheimer disease"],"prefix":"10.1016","volume":"1790","author":[{"given":"Andreas","family":"Kern","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Behl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbagen.2009.07.016_bib1","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1152\/physrev.2001.81.2.741","article-title":"Alzheimer's disease: genes, proteins, and therapy","volume":"81","author":"Selkoe","year":"2001","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.bbagen.2009.07.016_bib2","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1007\/BF00308809","article-title":"Neuropathological stageing of Alzheimer-related changes","volume":"82","author":"Braak","year":"1991","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.bbagen.2009.07.016_bib3","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1007\/0-387-23226-5_13","article-title":"The interaction of amyloid-beta with ApoE","volume":"38","author":"Carter","year":"2005","journal-title":"Subcell. Biochem."},{"key":"10.1016\/j.bbagen.2009.07.016_bib4","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1038\/nature06516","article-title":"The coming acceleration of global population ageing","volume":"451","author":"Lutz","year":"2008","journal-title":"Nature"},{"key":"10.1016\/j.bbagen.2009.07.016_bib5","doi-asserted-by":"crossref","unstructured":"C.P. Ferri, M. Prince, C. Brayne et al., Global prevalence of dementia: a Delphi consensus study, Lancet 366 2112\u20132117.","DOI":"10.1016\/S0140-6736(05)67889-0"},{"key":"10.1016\/j.bbagen.2009.07.016_bib6","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1111\/j.1525-1497.2001.10123.x","article-title":"National estimates of the quantity and cost of informal caregiving for the elderly with dementia","volume":"16","author":"Langa","year":"2001","journal-title":"J. Gen. Intern. Med."},{"key":"10.1016\/j.bbagen.2009.07.016_bib7","first-page":"S4","article-title":"Prevalence of dementia and major subtypes in Europe: a collaborative study of population-based cohorts","volume":"54","author":"Lobo","year":"2000","journal-title":"Neurology"},{"key":"10.1016\/j.bbagen.2009.07.016_bib8","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1016\/S1474-4422(08)70169-8","article-title":"Alzheimer's disease and vascular dementia in developing countries: prevalence, management, and risk factors","volume":"7","author":"Kalaria","year":"2008","journal-title":"Lancet Neurology"},{"key":"10.1016\/j.bbagen.2009.07.016_bib9","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1177\/0891988707308806","article-title":"Cognitive-behavioral profiles of neurodegenerative dementias: beyond Alzheimer's disease","volume":"20","author":"Levy","year":"2007","journal-title":"J. Geriatr. Psychiatry Neurol."},{"key":"10.1016\/j.bbagen.2009.07.016_bib10","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1001\/archneur.56.3.303","article-title":"Mild cognitive impairment: clinical characterization and outcome","volume":"56","author":"Petersen","year":"1999","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.bbagen.2009.07.016_bib11","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1212\/WNL.56.9.1133","article-title":"Practice parameter: Early detection of dementia: mild cognitive impairment (an evidence-based review): Report of the Quality Standards Subcommittee of the American Academy of Neurology","volume":"56","author":"Petersen","year":"2001","journal-title":"Neurology"},{"key":"10.1016\/j.bbagen.2009.07.016_bib12","doi-asserted-by":"crossref","first-page":"1793","DOI":"10.1016\/S0140-6736(97)01007-6","article-title":"Prevalence and severity of cognitive impairment with and without dementia in an elderly population","volume":"349","author":"Graham","year":"1997","journal-title":"Lancet"},{"key":"10.1016\/j.bbagen.2009.07.016_bib13","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/0022-3956(75)90026-6","article-title":"\u201cMini-mental state\u201d. A practical method for grading the cognitive state of patients for the clinician","volume":"12","author":"Folstein","year":"1975","journal-title":"J. Psychiatr. Res."},{"key":"10.1016\/j.bbagen.2009.07.016_bib14","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1192\/bjp.140.6.566","article-title":"A new clinical scale for the staging of dementia","volume":"140","author":"Hughes","year":"1982","journal-title":"Br. J. Psychiatry"},{"key":"10.1016\/j.bbagen.2009.07.016_bib15","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1176\/ajp.139.9.1136","article-title":"The Global Deterioration Scale for assessment of primary degenerative dementia","volume":"139","author":"Reisberg","year":"1982","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.bbagen.2009.07.016_bib16","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1038\/nrn1809","article-title":"Neural plasticity in the ageing brain","volume":"7","author":"Burke","year":"2006","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.bbagen.2009.07.016_bib17","doi-asserted-by":"crossref","first-page":"4703","DOI":"10.1073\/pnas.052587399","article-title":"Mapping the evolution of regional atrophy in Alzheimer's disease: unbiased analysis of fluid-registered serial MRI","volume":"99","author":"Scahill","year":"2002","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbagen.2009.07.016_bib18","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1212\/01.WNL.0000110315.26026.EF","article-title":"Comparison of different MRI brain atrophy rate measures with clinical disease progression in AD","volume":"62","author":"Jack","year":"2004","journal-title":"Neurology"},{"key":"10.1016\/j.bbagen.2009.07.016_bib19","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/0306-4522(95)90397-P","article-title":"Close-meshed prevalence rates of different stages as a tool to uncover the rate of Alzheimer's disease-related neurofibrillary changes","volume":"64","author":"Ohm","year":"1995","journal-title":"Neuroscience"},{"key":"10.1016\/j.bbagen.2009.07.016_bib20","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1097\/nen.0b013e31815c5efb","article-title":"Clinicopathologic correlations in a large Alzheimer disease center autopsy cohort: neuritic plaques and neurofibrillary tangles \u201cdo count\u201d when staging disease severity","volume":"66","author":"Nelson","year":"2007","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.bbagen.2009.07.016_bib21","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1212\/01.WNL.0000063311.58879.01","article-title":"Tangle and neuron numbers, but not amyloid load, predict cognitive status in Alzheimer's disease","volume":"60","author":"Giannakopoulos","year":"2003","journal-title":"Neurology"},{"key":"10.1016\/j.bbagen.2009.07.016_bib22","doi-asserted-by":"crossref","first-page":"1984","DOI":"10.1212\/01.WNL.0000129697.01779.0A","article-title":"The importance of neuritic plaques and tangles to the development and evolution of AD","volume":"62","author":"Tiraboschi","year":"2004","journal-title":"Neurology"},{"key":"10.1016\/j.bbagen.2009.07.016_bib23","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1111\/j.1750-3639.2008.00147.x","article-title":"Staging of neurofibrillary pathology in Alzheimer's disease: a study of the BrainNet Europe Consortium","volume":"18","author":"Alafuzoff","year":"2008","journal-title":"Brain Pathol."},{"key":"10.1016\/j.bbagen.2009.07.016_bib24","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1212\/01.wnl.0000324924.91351.7d","article-title":"MRI correlates of neurofibrillary tangle pathology at autopsy: a voxel-based morphometry study","volume":"71","author":"Whitwell","year":"2008","journal-title":"Neurology"},{"key":"10.1016\/j.bbagen.2009.07.016_bib25","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1002\/ana.20889","article-title":"Amyloid load and cerebral atrophy in Alzheimer's disease: an 11C-PIB positron emission tomography study","volume":"60","author":"Archer","year":"2006","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.bbagen.2009.07.016_bib26","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1212\/01.WNL.0000079053.77227.14","article-title":"Changes in premorbid brain volume predict Alzheimer's disease pathology","volume":"61","author":"Silbert","year":"2003","journal-title":"Neurology"},{"key":"10.1016\/j.bbagen.2009.07.016_bib27","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1002\/ana.21223","article-title":"Beta-amyloid burden is not associated with rates of brain atrophy","volume":"63","author":"Josephs","year":"2008","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.bbagen.2009.07.016_bib28","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/S0166-2236(97)01168-5","article-title":"Alzheimer's disease: a re-examination of the amyloid hypothesis","volume":"21","author":"Neve","year":"1998","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.bbagen.2009.07.016_bib29","doi-asserted-by":"crossref","first-page":"1571","DOI":"10.1001\/jama.283.12.1571","article-title":"Correlation between elevated levels of amyloid beta-peptide in the brain and cognitive decline","volume":"283","author":"Naslund","year":"2000","journal-title":"Jama"},{"key":"10.1016\/j.bbagen.2009.07.016_bib30","doi-asserted-by":"crossref","first-page":"14052","DOI":"10.1073\/pnas.0805902105","article-title":"Peripheral Abeta subspecies as risk biomarkers of Alzheimer's disease","volume":"105","author":"Schupf","year":"2008","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbagen.2009.07.016_bib31","doi-asserted-by":"crossref","first-page":"re1","DOI":"10.1126\/sageke.2006.6.re1","article-title":"The development of amyloid beta protein deposits in the aged brain","volume":"2006","author":"Thal","year":"2006","journal-title":"Sci. Aging Knowledge Environ."},{"key":"10.1016\/j.bbagen.2009.07.016_bib32","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1038\/373523a0","article-title":"Alzheimer-type neuropathology in transgenic mice overexpressing V717F beta-amyloid precursor protein","volume":"373","author":"Games","year":"1995","journal-title":"Nature"},{"key":"10.1016\/j.bbagen.2009.07.016_bib33","doi-asserted-by":"crossref","first-page":"7053","DOI":"10.1523\/JNEUROSCI.17-18-07053.1997","article-title":"Abeta deposition is associated with neuropil changes, but not with overt neuronal loss in the human amyloid precursor protein V717F (PDAPP) transgenic mouse","volume":"17","author":"Irizarry","year":"1997","journal-title":"J. Neurosci."},{"key":"10.1016\/j.bbagen.2009.07.016_bib34","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1602\/neurorx.2.3.423","article-title":"Transgenic models of Alzheimer's disease: learning from animals","volume":"2","author":"Spires","year":"2005","journal-title":"NeuroRx"},{"key":"10.1016\/j.bbagen.2009.07.016_bib35","doi-asserted-by":"crossref","first-page":"3628","DOI":"10.1523\/JNEUROSCI.22-09-03628.2002","article-title":"A hippocampal NR2B deficit can mimic age-related changes in long-term potentiation and spatial learning in the Fischer 344 rat","volume":"22","author":"Clayton","year":"2002","journal-title":"J. Neurosci."},{"key":"10.1016\/j.bbagen.2009.07.016_bib36","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/S0165-0173(99)00017-X","article-title":"Involvement of hippocampal synaptic plasticity in age-related memory decline","volume":"30","author":"Foster","year":"1999","journal-title":"Brain Res. Rev."},{"key":"10.1016\/j.bbagen.2009.07.016_bib37","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/S0301-0082(02)00126-0","article-title":"Impact of aging on hippocampal function: plasticity, network dynamics, and cognition","volume":"69","author":"Rosenzweig","year":"2003","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.bbagen.2009.07.016_bib38","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1038\/19978","article-title":"Dendritic spine changes associated with hippocampal long-term synaptic plasticity","volume":"399","author":"Engert","year":"1999","journal-title":"Nature"},{"key":"10.1016\/j.bbagen.2009.07.016_bib39","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1046\/j.1460-9568.1998.00137.x","article-title":"Layer-specific dendritic regression of pyramidal cells with ageing in the human prefrontal cortex","volume":"10","author":"de Brabander","year":"1998","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.bbagen.2009.07.016_bib40","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1007\/BF00687009","article-title":"Age-related changes of pyramidal cell basal dendrites in layers III and V of human motor cortex: a quantitative Golgi study","volume":"65","author":"Nakamura","year":"1985","journal-title":"Acta Neuropathol."},{"issue":"Suppl. 1","key":"10.1016\/j.bbagen.2009.07.016_bib41","doi-asserted-by":"crossref","first-page":"S100","DOI":"10.1038\/sj.bjp.0706444","article-title":"The glutamate story","volume":"147","author":"Watkins","year":"2006","journal-title":"Br. J. Pharmacol"},{"key":"10.1016\/j.bbagen.2009.07.016_bib42","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1038\/361031a0","article-title":"A synaptic model of memory: long-term potentiation in the hippocampus","volume":"361","author":"Bliss","year":"1993","journal-title":"Nature"},{"key":"10.1016\/j.bbagen.2009.07.016_bib43","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1016\/S0165-6147(96)80008-3","article-title":"NMDA receptors: from genes to channels","volume":"17","author":"Sucher","year":"1996","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.bbagen.2009.07.016_bib44","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1002\/syn.20563","article-title":"Glutamate receptor subunits expression in memory-associated brain structures: regional variations and effects of aging","volume":"62","author":"Liu","year":"2008","journal-title":"Synapse"},{"key":"10.1016\/j.bbagen.2009.07.016_bib45","doi-asserted-by":"crossref","first-page":"e70","DOI":"10.2741\/A368","article-title":"The aging of the NMDA receptor complex","volume":"3","author":"Magnusson","year":"1998","journal-title":"Front. Biosci."},{"key":"10.1016\/j.bbagen.2009.07.016_bib46","doi-asserted-by":"crossref","first-page":"3338","DOI":"10.1096\/fasebj.6.15.1464368","article-title":"Mechanisms of excitotoxicity in neurologic diseases","volume":"6","author":"Beal","year":"1992","journal-title":"FASEB J."},{"key":"10.1016\/j.bbagen.2009.07.016_bib47","doi-asserted-by":"crossref","first-page":"S61","DOI":"10.3233\/JAD-2004-6S610","article-title":"Paradigm shift in NMDA receptor antagonist drug development: molecular mechanism of uncompetitive inhibition by memantine in the treatment of Alzheimer's disease and other neurologic disorders","volume":"6","author":"Lipton","year":"2004","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.bbagen.2009.07.016_bib48","first-page":"117","article-title":"Memantine prevents progressive functional neurodegeneration in rats","volume":"46","author":"Heim","year":"1995","journal-title":"J. Neural. Transm. Suppl."},{"key":"10.1016\/j.bbagen.2009.07.016_bib49","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/0006-8993(93)90464-X","article-title":"NMDA receptor-mediated glutamate toxicity of cultured cerebellar, cortical and mesencephalic neurons: neuroprotective properties of amantadine and memantine","volume":"613","author":"Weller","year":"1993","journal-title":"Brain Res."},{"key":"10.1016\/j.bbagen.2009.07.016_bib50","doi-asserted-by":"crossref","first-page":"97","DOI":"10.3233\/JAD-2008-13110","article-title":"Memantine treatment in patients with mild to moderate Alzheimer's disease: results of a randomised, double-blind, placebo-controlled 6-month study","volume":"13","author":"Bakchine","year":"2008","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.bbagen.2009.07.016_bib51","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1056\/NEJMoa013128","article-title":"Memantine in moderate-to-severe Alzheimer's disease","volume":"348","author":"Reisberg","year":"2003","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.bbagen.2009.07.016_bib52","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1001\/jama.291.3.317","article-title":"Memantine treatment in patients with moderate to severe Alzheimer disease already receiving donepezil: a randomized controlled trial","volume":"291","author":"Tariot","year":"2004","journal-title":"Jama"},{"key":"10.1016\/j.bbagen.2009.07.016_bib53","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1124\/jpet.104.071027","article-title":"Memantine Improves Spatial Learning in a Transgenic Mouse Model of Alzheimer's disease","volume":"311","author":"Minkeviciene","year":"2004","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.bbagen.2009.07.016_bib54","doi-asserted-by":"crossref","first-page":"2784","DOI":"10.1002\/jnr.21713","article-title":"Memantine leads to behavioral improvement and amyloid reduction in Alzheimer's-disease-model transgenic mice shown as by micromagnetic resonance imaging","volume":"86","author":"Scholtzova","year":"2008","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/j.bbagen.2009.07.016_bib55","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1097\/NEN.0b013e31816a1df3","article-title":"Cholinergic neuronal and axonal abnormalities are present early in aging and in Alzheimer disease","volume":"67","author":"Geula","year":"2008","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.bbagen.2009.07.016_bib56","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1093\/brain\/awh671","article-title":"Cholinergic challenge in Alzheimer patients and mild cognitive impairment differentially affects hippocampal activation\u2014a pharmacological fMRI study","volume":"129","author":"Goekoop","year":"2006","journal-title":"Brain"},{"key":"10.1016\/j.bbagen.2009.07.016_bib57","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.neurobiolaging.2004.12.005","article-title":"Inhibition of hippocampal function in mild cognitive impairment: targeting the cholinergic hypothesis","volume":"27","author":"Gron","year":"2006","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.bbagen.2009.07.016_bib58","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1006\/exnr.2000.7397","article-title":"On neurodegenerative diseases, models, and treatment strategies: lessons learned and lessons forgotten a generation following the cholinergic hypothesis","volume":"163","author":"Bartus","year":"2000","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.bbagen.2009.07.016_bib59","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1126\/science.7058341","article-title":"Alzheimer's disease and senile dementia: loss of neurons in the basal forebrain","volume":"215","author":"Whitehouse","year":"1982","journal-title":"Science"},{"key":"10.1016\/j.bbagen.2009.07.016_bib60","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1046\/j.1471-4159.1995.64020749.x","article-title":"Neurochemical correlates of dementia severity in Alzheimer's disease: relative importance of the cholinergic deficits","volume":"64","author":"Bierer","year":"1995","journal-title":"J. Neurochem."},{"key":"10.1016\/j.bbagen.2009.07.016_bib61","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1001\/archneur.62.3.425","article-title":"Reduction of choline acetyltransferase activity in primary visual cortex in mild to moderate Alzheimer's disease","volume":"62","author":"Ikonomovic","year":"2005","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.bbagen.2009.07.016_bib62","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1586\/14737175.7.10.1243","article-title":"Donepezil for Alzheimer's disease","volume":"7","author":"Benjamin","year":"2007","journal-title":"Expert Rev. Neurother."},{"key":"10.1016\/j.bbagen.2009.07.016_bib63","doi-asserted-by":"crossref","first-page":"234","DOI":"10.2165\/00002512-199710030-00007","article-title":"Donepezil","volume":"10","author":"Bryson","year":"1997","journal-title":"Drugs Aging"},{"key":"10.1016\/j.bbagen.2009.07.016_bib64","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1001\/archneur.57.1.94","article-title":"Donepezil therapy in clinical practice: a randomized crossover study","volume":"57","author":"Greenberg","year":"2000","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.bbagen.2009.07.016_bib65","first-page":"211","article-title":"Efficacy and safety of donepezil, galantamine, and rivastigmine for the treatment of Alzheimer's disease: a systematic review and meta-analysis","volume":"3","author":"Hansen","year":"2008","journal-title":"Clin. Interv. Aging"},{"key":"10.1016\/j.bbagen.2009.07.016_bib66","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1212\/WNL.56.1.42","article-title":"Cardiovascular risk factors and cognitive decline in middle-aged adults","volume":"56","author":"Knopman","year":"2001","journal-title":"Neurology"},{"key":"10.1016\/j.bbagen.2009.07.016_bib67","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1016\/S0140-6736(96)90608-X","article-title":"15-year longitudinal study of blood pressure and dementia","volume":"347","author":"Skoog","year":"1996","journal-title":"Lancet"},{"key":"10.1016\/j.bbagen.2009.07.016_bib68","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1212\/01.WNL.0000149519.47454.F2","article-title":"Midlife cardiovascular risk factors and risk of dementia in late life","volume":"64","author":"Whitmer","year":"2005","journal-title":"Neurology"},{"key":"10.1016\/j.bbagen.2009.07.016_bib69","doi-asserted-by":"crossref","first-page":"1667","DOI":"10.1212\/01.WNL.0000098934.18300.BE","article-title":"Low blood pressure and the risk of dementia in very old individuals","volume":"61","author":"Verghese","year":"2003","journal-title":"Neurology"},{"key":"10.1016\/j.bbagen.2009.07.016_bib70","first-page":"106","article-title":"Evolution of blood pressure in patients with Alzheimer's disease: a one year survey of a French Cohort (REAL.FR)","volume":"9","author":"Hanon","year":"2005","journal-title":"J. Nutr. Health Aging"},{"key":"10.1016\/j.bbagen.2009.07.016_bib71","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1161\/01.STR.0000125859.71051.83","article-title":"Interaction between hypertension, apoE, and cerebral white matter lesions","volume":"35","author":"de Leeuw","year":"2004","journal-title":"Stroke"},{"key":"10.1016\/j.bbagen.2009.07.016_bib72","doi-asserted-by":"crossref","first-page":"2046","DOI":"10.1001\/archinte.162.18.2046","article-title":"The prevention of dementia with antihypertensive treatment: new evidence from the Systolic Hypertension in Europe (Syst-Eur) study","volume":"162","author":"Forette","year":"2002","journal-title":"Arch. Intern. Med."},{"key":"10.1016\/j.bbagen.2009.07.016_bib73","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1001\/archinte.163.9.1069","article-title":"Effects of blood pressure lowering with perindopril and indapamide therapy on dementia and cognitive decline in patients with cerebrovascular disease","volume":"163","author":"Tzourio","year":"2003","journal-title":"Arch. Intern. Med."},{"key":"10.1016\/j.bbagen.2009.07.016_bib74","doi-asserted-by":"crossref","first-page":"2154","DOI":"10.1001\/archinte.154.19.2154","article-title":"Impact of the treatment of isolated systolic hypertension on behavioral variables. Results from the systolic hypertension in the elderly program","volume":"154","author":"Applegate","year":"1994","journal-title":"Arch. Intern. Med."},{"key":"10.1016\/j.bbagen.2009.07.016_bib75","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1097\/01.hjh.0000133730.47372.4c","article-title":"The Study on COgnition and Prognosis in the Elderly (SCOPE); outcomes in patients not receiving add-on therapy after randomization","volume":"22","author":"Lithell","year":"2004","journal-title":"J. Hypertens."},{"key":"10.1016\/j.bbagen.2009.07.016_bib76","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1136\/bmj.312.7034.801","article-title":"Is the cognitive function of older patients affected by antihypertensive treatment? Results from 54 months of the Medical Research Council's trial of hypertension in older adults","volume":"312","author":"Prince","year":"1996","journal-title":"Bmj"},{"key":"10.1016\/j.bbagen.2009.07.016_bib77","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1212\/01.wnl.0000234037.91185.99","article-title":"Association of metabolic syndrome with Alzheimer disease: a population-based study","volume":"67","author":"Vanhanen","year":"2006","journal-title":"Neurology"},{"key":"10.1016\/j.bbagen.2009.07.016_bib78","doi-asserted-by":"crossref","first-page":"2255","DOI":"10.1161\/01.ATV.20.10.2255","article-title":"Metabolic cardiovascular syndrome and risk of dementia in Japanese-American elderly men. The Honolulu-Asia aging study","volume":"20","author":"Kalmijn","year":"2000","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.bbagen.2009.07.016_bib79","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.ijdevneu.2005.11.014","article-title":"Contribution of inflammatory processes to Alzheimer's disease: molecular mechanisms","volume":"24","author":"Sastre","year":"2006","journal-title":"Int. J. Dev. Neurosci."},{"key":"10.1016\/j.bbagen.2009.07.016_bib80","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1111\/j.1471-4159.2006.04369.x","article-title":"Astrocytes aged in vitro show a decreased neuroprotective capacity","volume":"101","author":"Pertusa","year":"2007","journal-title":"J. Neurochem."},{"key":"10.1016\/j.bbagen.2009.07.016_bib81","doi-asserted-by":"crossref","unstructured":"J.E. Simpson, P.G. Ince, G. Lace, et al., Astrocyte phenotype in relation to Alzheimer-type pathology in the ageing brain, Neurobiol. Aging (in press). doi:10.1016\/j.neurobiolaging.2008.05.015.","DOI":"10.1016\/j.neurobiolaging.2008.05.015"},{"key":"10.1016\/j.bbagen.2009.07.016_bib82","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1016\/j.neurobiolaging.2004.01.007","article-title":"Contribution of glial cells to the development of amyloid plaques in Alzheimer's disease","volume":"25","author":"Nagele","year":"2004","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.bbagen.2009.07.016_bib83","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1002\/glia.440020605","article-title":"Patterns of gliosis in Alzheimer's disease and aging cerebrum","volume":"2","author":"Beach","year":"1989","journal-title":"Glia"},{"key":"10.1016\/j.bbagen.2009.07.016_bib84","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/S0197-4580(02)00090-8","article-title":"Immune reactive cells in senile plaques and cognitive decline in Alzheimer's disease","volume":"24","author":"Vehmas","year":"2003","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.bbagen.2009.07.016_bib85","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1046\/j.1471-4159.2001.00075.x","article-title":"Activation of microglia by secreted amyloid precursor protein evokes release of glutamate by cystine exchange and attenuates synaptic function","volume":"76","author":"Barger","year":"2001","journal-title":"J. Neurochem."},{"key":"10.1016\/j.bbagen.2009.07.016_bib86","doi-asserted-by":"crossref","first-page":"21362","DOI":"10.1074\/jbc.M600504200","article-title":"Tumor necrosis factor-alpha induces neurotoxicity via glutamate release from hemichannels of activated microglia in an autocrine manner","volume":"281","author":"Takeuchi","year":"2006","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbagen.2009.07.016_bib87","doi-asserted-by":"crossref","first-page":"2449","DOI":"10.1111\/j.1471-4159.2008.05553.x","article-title":"Activation of microglia with zymosan promotes excitatory amino acid release via volume-regulated anion channels: the role of NADPH oxidases","volume":"106","author":"Timothy","year":"2008","journal-title":"J. Neurochem."},{"key":"10.1016\/j.bbagen.2009.07.016_bib88","doi-asserted-by":"crossref","first-page":"2566","DOI":"10.1523\/JNEUROSCI.4998-04.2005","article-title":"Beta-amyloid-stimulated microglia induce neuron death via synergistic stimulation of tumor necrosis factor alpha and NMDA receptors","volume":"25","author":"Floden","year":"2005","journal-title":"J. Neurosci."},{"key":"10.1016\/j.bbagen.2009.07.016_bib89","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1212\/WNL.45.8.1441","article-title":"Do nonsteroidal anti-inflammatory drugs decrease the risk for Alzheimer's disease? The Rotterdam Study","volume":"45","author":"Andersen","year":"1995","journal-title":"Neurology"},{"key":"10.1016\/j.bbagen.2009.07.016_bib90","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1212\/WNL.44.2.227","article-title":"Inverse association of anti-inflammatory treatments and Alzheimer's disease: initial results of a co-twin control study","volume":"44","author":"Breitner","year":"1994","journal-title":"Neurology"},{"key":"10.1016\/j.bbagen.2009.07.016_bib91","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1016\/S0197-4580(98)00096-7","article-title":"NSAIDs and incident Alzheimer's disease. The Rotterdam Study","volume":"19","author":"in't Veld","year":"1998","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.bbagen.2009.07.016_bib92","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1001\/archneur.2008.65.7.nct70006","article-title":"Cognitive function over time in the Alzheimer's Disease Anti-inflammatory Prevention Trial (ADAPT): results of a randomized, controlled trial of naproxen and celecoxib","volume":"65","author":"Martin","year":"2008","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.bbagen.2009.07.016_bib93","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1111\/j.1532-5415.1972.tb00787.x","article-title":"The biologic clock: the mitochondria?","volume":"20","author":"Harman","year":"1972","journal-title":"J. Am. Geriatr. Soc."},{"key":"10.1016\/j.bbagen.2009.07.016_bib94","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1111\/j.1474-9726.2007.00349.x","article-title":"Mitochondrially encoded cysteine predicts animal lifespan","volume":"7","author":"Moosmann","year":"2008","journal-title":"Aging Cell"},{"key":"10.1016\/j.bbagen.2009.07.016_bib95","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1096\/fasebj.9.7.7737461","article-title":"Oxidative processes and antioxidative defence mechanisms in the aging brain","volume":"9","author":"Reiter","year":"1995","journal-title":"FASEB J."},{"key":"10.1016\/j.bbagen.2009.07.016_bib96","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/S0891-5849(02)00883-3","article-title":"Antioxidant neuroprotection in Alzheimer's disease as preventive and therapeutic approach","volume":"33","author":"Behl","year":"2002","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.bbagen.2009.07.016_bib97","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1517\/13543784.11.10.1407","article-title":"Antioxidants as treatment for neurodegenerative disorders","volume":"11","author":"Moosmann","year":"2002","journal-title":"Expert. Opin. Investig. Drugs"},{"key":"10.1016\/j.bbagen.2009.07.016_bib98","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.brainres.2006.03.063","article-title":"Age-related changes in glutathione and glutathione-related enzymes in rat brain","volume":"1090","author":"Zhu","year":"2006","journal-title":"Brain Res."},{"key":"10.1016\/j.bbagen.2009.07.016_bib99","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/0197-4580(95)80007-E","article-title":"Studies on lipid peroxidation and protein oxidation in the aging brain","volume":"16","author":"Cini","year":"1995","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.bbagen.2009.07.016_bib100","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/S0197-4580(98)00082-7","article-title":"Dietary antioxidant supplementation reverses age-related neuronal changes","volume":"19","author":"O'Donnell","year":"1998","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.bbagen.2009.07.016_bib101","first-page":"295","article-title":"Lipid peroxidation and tissue damage","volume":"13","author":"Mylonas","year":"1999","journal-title":"In Vivo"},{"key":"10.1016\/j.bbagen.2009.07.016_bib102","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1515\/REVNEURO.1998.9.2.105","article-title":"Roles of lipid peroxidation in modulation of cellular signaling pathways, cell dysfunction, and death in the nervous system","volume":"9","author":"Keller","year":"1998","journal-title":"Rev. Neurosci."},{"key":"10.1016\/j.bbagen.2009.07.016_bib103","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1001\/archneur.64.7.954","article-title":"Damage to lipids, proteins, DNA, and RNA in mild cognitive impairment","volume":"64","author":"Markesbery","year":"2007","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.bbagen.2009.07.016_bib104","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1080\/09540260600583007","article-title":"Lipids and the pathogenesis of Alzheimer's disease: Is there a link?","volume":"18","author":"Mielke","year":"2006","journal-title":"Int. Rev. Psychiatry"},{"key":"10.1016\/j.bbagen.2009.07.016_bib105","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1016\/j.bbrc.2005.07.201","article-title":"Age-associated changes in protein oxidation and proteasome activities in rat brain: modulation by antioxidants","volume":"336","author":"Abd El Mohsen","year":"2005","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.bbagen.2009.07.016_bib106","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1016\/j.neurobiolaging.2005.05.014","article-title":"Proteomics analysis provides insight into caloric restriction mediated oxidation and expression of brain proteins associated with age-related impaired cellular processes: mitochondrial dysfunction, glutamate dysregulation and impaired protein synthesis","volume":"27","author":"Poon","year":"2006","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.bbagen.2009.07.016_bib107","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.lfs.2005.04.044","article-title":"Aging affects oxidative state in hippocampus, hypothalamus and adrenal glands of Wistar rats","volume":"78","author":"Rodrigues Siqueira","year":"2005","journal-title":"Life Sci."},{"key":"10.1016\/j.bbagen.2009.07.016_bib108","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1080\/10715760802255764","article-title":"Malondialdehyde, carbonyl proteins and albumin-disulphide as useful oxidative markers in mild cognitive impairment and Alzheimer's disease","volume":"42","author":"Greilberger","year":"2008","journal-title":"Free Radic. Res."},{"key":"10.1016\/j.bbagen.2009.07.016_bib109","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1212\/01.WNL.0000156156.13641.BA","article-title":"Evidence of increased oxidative damage in subjects with mild cognitive impairment","volume":"64","author":"Keller","year":"2005","journal-title":"Neurology"},{"key":"10.1016\/j.bbagen.2009.07.016_bib110","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1038\/ng1769","article-title":"High levels of mitochondrial DNA deletions in substantia nigra neurons in aging and Parkinson disease","volume":"38","author":"Bender","year":"2006","journal-title":"Nat. Genet."},{"key":"10.1016\/j.bbagen.2009.07.016_bib111","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1038\/ng1292-324","article-title":"Mitochondrial DNA deletions in human brain: regional variability and increase with advanced age","volume":"2","author":"Corral-Debrinski","year":"1992","journal-title":"Nat. Genet."},{"key":"10.1016\/j.bbagen.2009.07.016_bib112","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1111\/j.1471-4159.2005.03615.x","article-title":"Increased oxidative damage in nuclear and mitochondrial DNA in mild cognitive impairment","volume":"96","author":"Wang","year":"2006","journal-title":"J. Neurochem."},{"key":"10.1016\/j.bbagen.2009.07.016_bib113","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1111\/j.1471-4159.2005.03053.x","article-title":"Increased oxidative damage in nuclear and mitochondrial DNA in Alzheimer's disease","volume":"93","author":"Wang","year":"2005","journal-title":"J. Neurochem."},{"key":"10.1016\/j.bbagen.2009.07.016_bib114","doi-asserted-by":"crossref","first-page":"699","DOI":"10.2174\/138161206775474297","article-title":"Antioxidants as a potential therapy against age-related neurodegenerative diseases: amyloid Beta toxicity and Alzheimer's disease","volume":"12","author":"Hajieva","year":"2006","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.bbagen.2009.07.016_bib115","first-page":"230","article-title":"Antioxidant intake and cognitive function of elderly men and women: the Cache County Study","volume":"11","author":"Wengreen","year":"2007","journal-title":"J. Nutr. Health Aging"},{"key":"10.1016\/j.bbagen.2009.07.016_bib116","doi-asserted-by":"crossref","first-page":"2184","DOI":"10.1001\/archinte.167.20.2184","article-title":"A randomized trial of beta carotene supplementation and cognitive function in men: the Physicians' Health Study II","volume":"167","author":"Grodstein","year":"2007","journal-title":"Arch. Intern. Med."},{"key":"10.1016\/j.bbagen.2009.07.016_bib117","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1056\/NEJM199704243361704","article-title":"A controlled trial of selegiline, alpha-tocopherol, or both as treatment for Alzheimer's disease. The Alzheimer's Disease Cooperative Study","volume":"336","author":"Sano","year":"1997","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.bbagen.2009.07.016_bib118","first-page":"CD002854","article-title":"Vitamin E for Alzheimer's disease and mild cognitive impairment","author":"Isaac","year":"2008","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.bbagen.2009.07.016_bib119","doi-asserted-by":"crossref","first-page":"2253","DOI":"10.1001\/jama.2008.683","article-title":"Ginkgo biloba for prevention of dementia: a randomized controlled trial","volume":"300","author":"Dekosky","year":"2008","journal-title":"Jama"},{"key":"10.1016\/j.bbagen.2009.07.016_bib120","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1016\/0006-291X(84)91209-9","article-title":"Alzheimer's disease and Down's syndrome: sharing of a unique cerebrovascular amyloid fibril protein","volume":"122","author":"Glenner","year":"1984","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.bbagen.2009.07.016_bib121","doi-asserted-by":"crossref","first-page":"2757","DOI":"10.1002\/j.1460-2075.1985.tb04000.x","article-title":"Neuronal origin of a cerebral amyloid: neurofibrillary tangles of Alzheimer's disease contain the same protein as the amyloid of plaque cores and blood vessels","volume":"4","author":"Masters","year":"1985","journal-title":"EMBO J."},{"key":"10.1016\/j.bbagen.2009.07.016_bib122","doi-asserted-by":"crossref","first-page":"3783","DOI":"10.1523\/JNEUROSCI.11-12-03783.1991","article-title":"Processing of beta-amyloid precursor protein in microglia and astrocytes favors an internal localization over constitutive secretion","volume":"11","author":"Haass","year":"1991","journal-title":"J. Neurosci."},{"key":"10.1016\/j.bbagen.2009.07.016_bib123","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1038\/sj.emboj.7600061","article-title":"Take five\u2014BACE and the gamma-secretase quartet conduct Alzheimer's amyloid beta-peptide generation","volume":"23","author":"Haass","year":"2004","journal-title":"EMBO J."},{"key":"10.1016\/j.bbagen.2009.07.016_bib124","doi-asserted-by":"crossref","first-page":"3922","DOI":"10.1073\/pnas.96.7.3922","article-title":"Constitutive and regulated alpha-secretase cleavage of Alzheimer's amyloid precursor protein by a disintegrin metalloprotease","volume":"96","author":"Lammich","year":"1999","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbagen.2009.07.016_bib125","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1126\/science.286.5440.735","article-title":"Beta-secretase cleavage of Alzheimer's amyloid precursor protein by the transmembrane aspartic protease BACE","volume":"286","author":"Vassar","year":"1999","journal-title":"Science"},{"key":"10.1016\/j.bbagen.2009.07.016_bib126","doi-asserted-by":"crossref","first-page":"24601","DOI":"10.1074\/jbc.M402248200","article-title":"Dissection of amyloid-beta precursor protein-dependent transcriptional transactivation","volume":"279","author":"Cao","year":"2004","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbagen.2009.07.016_bib127","doi-asserted-by":"crossref","first-page":"33985","DOI":"10.1074\/jbc.M705248200","article-title":"Active gamma-secretase complexes contain only one of each component","volume":"282","author":"Sato","year":"2007","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbagen.2009.07.016_bib128","doi-asserted-by":"crossref","first-page":"35235","DOI":"10.1074\/jbc.C100357200","article-title":"Distinct intramembrane cleavage of the beta-amyloid precursor protein family resembling gamma-secretase-like cleavage of Notch","volume":"276","author":"Gu","year":"2001","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbagen.2009.07.016_bib129","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1523\/JNEUROSCI.1575-04.2005","article-title":"Longer forms of amyloid beta protein: implications for the mechanism of intramembrane cleavage by gamma-secretase","volume":"25","author":"Qi-Takahara","year":"2005","journal-title":"J. Neurosci."},{"key":"10.1016\/j.bbagen.2009.07.016_bib130","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1126\/science.1566067","article-title":"Alzheimer's disease: the amyloid cascade hypothesis","volume":"256","author":"Hardy","year":"1992","journal-title":"Science"},{"key":"10.1016\/j.bbagen.2009.07.016_bib131","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1016\/j.cell.2008.05.048","article-title":"A polymorphism in CALHM1 influences Ca2+ homeostasis, Abeta levels, and Alzheimer's disease risk","volume":"133","author":"Dreses-Werringloer","year":"2008","journal-title":"Cell"},{"key":"10.1016\/j.bbagen.2009.07.016_bib132","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1111\/j.1365-2788.2006.00902.x","article-title":"Fifteen-year follow-up of 92 hospitalized adults with Down's syndrome: incidence of cognitive decline, its relationship to age and neuropathology","volume":"51","author":"Margallo-Lana","year":"2007","journal-title":"J. Intellect. Disabil. Res."},{"key":"10.1016\/j.bbagen.2009.07.016_bib133","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1126\/science.2474201","article-title":"Neurotoxicity of a fragment of the amyloid precursor associated with Alzheimer's disease","volume":"245","author":"Yankner","year":"1989","journal-title":"Science"},{"key":"10.1016\/j.bbagen.2009.07.016_bib134","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.1126\/science.8191290","article-title":"An increased percentage of long amyloid beta protein secreted by familial amyloid beta protein precursor (beta APP717) mutants","volume":"264","author":"Suzuki","year":"1994","journal-title":"Science"},{"key":"10.1016\/j.bbagen.2009.07.016_bib135","doi-asserted-by":"crossref","first-page":"12243","DOI":"10.1073\/pnas.91.25.12243","article-title":"Beta-amyloid neurotoxicity requires fibril formation and is inhibited by Congo red","volume":"91","author":"Lorenzo","year":"1994","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbagen.2009.07.016_bib136","doi-asserted-by":"crossref","first-page":"6448","DOI":"10.1073\/pnas.95.11.6448","article-title":"Diffusible, nonfibrillar ligands derived from Abeta1\u201342 are potent central nervous system neurotoxins","volume":"95","author":"Lambert","year":"1998","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbagen.2009.07.016_bib137","doi-asserted-by":"crossref","first-page":"4749","DOI":"10.1074\/jbc.R800036200","article-title":"Amyloid beta-protein assembly and Alzheimer's disease","volume":"284","author":"Roychaudhuri","year":"2009","journal-title":"J. Biol. Chem"},{"key":"10.1016\/j.bbagen.2009.07.016_bib138","doi-asserted-by":"crossref","first-page":"10738","DOI":"10.1073\/pnas.92.23.10738","article-title":"Amyloid beta peptide potentiates cytokine secretion by interleukin-1 beta-activated human astrocytoma cells","volume":"92","author":"Gitter","year":"1995","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbagen.2009.07.016_bib139","doi-asserted-by":"crossref","first-page":"5050","DOI":"10.4049\/jimmunol.152.10.5050","article-title":"beta-Amyloid activates complement by binding to a specific region of the collagen-like domain of the C1q A chain","volume":"152","author":"Jiang","year":"1994","journal-title":"J. Immunol."},{"key":"10.1016\/j.bbagen.2009.07.016_bib140","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1523\/JNEUROSCI.4042-03.2004","article-title":"Beta-amyloid peptides induce mitochondrial dysfunction and oxidative stress in astrocytes and death of neurons through activation of NADPH oxidase","volume":"24","author":"Abramov","year":"2004","journal-title":"J. Neurosci."},{"key":"10.1016\/j.bbagen.2009.07.016_bib141","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1093\/hmg\/ddl066","article-title":"Mitochondria are a direct site of A beta accumulation in Alzheimer's disease neurons: implications for free radical generation and oxidative damage in disease progression","volume":"15","author":"Manczak","year":"2006","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.bbagen.2009.07.016_bib142","doi-asserted-by":"crossref","first-page":"10573","DOI":"10.1073\/pnas.90.22.10573","article-title":"Giant multilevel cation channels formed by Alzheimer disease amyloid beta-protein [A beta P-(1\u201340)] in bilayer membranes","volume":"90","author":"Arispe","year":"1993","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbagen.2009.07.016_bib143","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/S0006-3495(97)78048-2","article-title":"Alzheimer's disease amyloid beta-protein forms Zn(2+)-sensitive, cation-selective channels across excised membrane patches from hypothalamic neurons","volume":"73","author":"Kawahara","year":"1997","journal-title":"Biophys. J."},{"key":"10.1016\/j.bbagen.2009.07.016_bib144","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1523\/JNEUROSCI.12-02-00376.1992","article-title":"beta-Amyloid peptides destabilize calcium homeostasis and render human cortical neurons vulnerable to excitotoxicity","volume":"12","author":"Mattson","year":"1992","journal-title":"J. Neurosci."},{"key":"10.1016\/j.bbagen.2009.07.016_bib145","doi-asserted-by":"crossref","first-page":"13379","DOI":"10.1074\/jbc.273.22.13379","article-title":"Amyloid beta protein-(1\u201342) forms calcium-permeable, Zn2+-sensitive channel","volume":"273","author":"Rhee","year":"1998","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbagen.2009.07.016_bib146","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1016\/0092-8674(94)90131-7","article-title":"Hydrogen peroxide mediates amyloid beta protein toxicity","volume":"77","author":"Behl","year":"1994","journal-title":"Cell"},{"key":"10.1016\/j.bbagen.2009.07.016_bib147","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1016\/S1471-4914(01)02173-6","article-title":"Evidence of oxidative damage in Alzheimer's disease brain: central role for amyloid beta-peptide","volume":"7","author":"Butterfield","year":"2001","journal-title":"Trends Mol. Med."},{"key":"10.1016\/j.bbagen.2009.07.016_bib148","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1111\/j.1474-9726.2008.00423.x","article-title":"Oxidative stress increases levels of endogenous amyloid-beta peptides secreted from primary chick brain neurons","volume":"7","author":"Goldsbury","year":"2008","journal-title":"Aging Cell"},{"key":"10.1016\/j.bbagen.2009.07.016_bib149","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1007\/s00702-004-0255-3","article-title":"Oxidative stress potentiates BACE1 gene expression and Abeta generation","volume":"112","author":"Tong","year":"2005","journal-title":"J. Neural. Transm."},{"key":"10.1016\/j.bbagen.2009.07.016_bib150","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1038\/456161a","article-title":"Neuroscience: the plaque plan","volume":"456","author":"Abbott","year":"2008","journal-title":"Nature"},{"key":"10.1016\/j.bbagen.2009.07.016_bib151","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1038\/nm0706-747","article-title":"The amyloid code","volume":"12","author":"Mandavilli","year":"2006","journal-title":"Nat. Med."},{"key":"10.1016\/j.bbagen.2009.07.016_bib152","doi-asserted-by":"crossref","first-page":"3213","DOI":"10.1097\/00001756-199710200-00006","article-title":"Block of LTP in rat hippocampus in vivo by beta-amyloid precursor protein fragments","volume":"8","author":"Cullen","year":"1997","journal-title":"Neuroreport"},{"key":"10.1016\/j.bbagen.2009.07.016_bib153","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1152\/jn.2001.85.2.708","article-title":"Blockade of long-term potentiation by beta-amyloid peptides in the CA1 region of the rat hippocampus in vivo","volume":"85","author":"Freir","year":"2001","journal-title":"J. Neurophysiol."},{"key":"10.1016\/j.bbagen.2009.07.016_bib154","doi-asserted-by":"crossref","first-page":"5703","DOI":"10.1523\/JNEUROSCI.21-15-05703.2001","article-title":"Generation of aggregated beta-amyloid in the rat hippocampus impairs synaptic transmission and plasticity and causes memory deficits","volume":"21","author":"Stephan","year":"2001","journal-title":"J. Neurosci."},{"key":"10.1016\/j.bbagen.2009.07.016_bib155","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1038\/6374","article-title":"Impaired synaptic plasticity and learning in aged amyloid precursor protein transgenic mice","volume":"2","author":"Chapman","year":"1999","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.bbagen.2009.07.016_bib156","doi-asserted-by":"crossref","first-page":"1858","DOI":"10.1523\/JNEUROSCI.22-05-01858.2002","article-title":"The relationship between Abeta and memory in the Tg2576 mouse model of Alzheimer's disease","volume":"22","author":"Westerman","year":"2002","journal-title":"J. Neurosci."},{"key":"10.1016\/j.bbagen.2009.07.016_bib157","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1016\/S0896-6273(03)00124-7","article-title":"APP processing and synaptic function","volume":"37","author":"Kamenetz","year":"2003","journal-title":"Neuron"},{"key":"10.1016\/j.bbagen.2009.07.016_bib158","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1016\/j.neuron.2005.10.028","article-title":"Synaptic activity regulates interstitial fluid amyloid-beta levels in vivo","volume":"48","author":"Cirrito","year":"2005","journal-title":"Neuron"},{"key":"10.1016\/j.bbagen.2009.07.016_bib159","doi-asserted-by":"crossref","first-page":"7212","DOI":"10.1523\/JNEUROSCI.1450-06.2006","article-title":"Synapse formation and function is modulated by the amyloid precursor protein","volume":"26","author":"Priller","year":"2006","journal-title":"J. Neurosci."},{"key":"10.1016\/j.bbagen.2009.07.016_bib160","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1073\/pnas.0608807104","article-title":"Amyloid precursor protein overexpression depresses excitatory transmission through both presynaptic and postsynaptic mechanisms","volume":"104","author":"Ting","year":"2007","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbagen.2009.07.016_bib161","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1016\/j.neuron.2006.10.035","article-title":"AMPAR removal underlies Abeta-induced synaptic depression and dendritic spine loss","volume":"52","author":"Hsieh","year":"2006","journal-title":"Neuron"},{"key":"10.1016\/j.bbagen.2009.07.016_bib162","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1016\/S0896-6273(00)80565-6","article-title":"Cell type and pathway dependence of synaptic AMPA receptor number and variability in the hippocampus","volume":"21","author":"Nusser","year":"1998","journal-title":"Neuron"},{"key":"10.1016\/j.bbagen.2009.07.016_bib163","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1038\/10172","article-title":"Different modes of expression of AMPA and NMDA receptors in hippocampal synapses","volume":"2","author":"Takumi","year":"1999","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.bbagen.2009.07.016_bib164","doi-asserted-by":"crossref","first-page":"10639","DOI":"10.1074\/jbc.M806508200","article-title":"{beta}-Amyloid impairs AMPA receptor trafficking and function by reducing Ca2+\/calmodulin-dependent protein kinase II synaptic distribution","volume":"284","author":"Gu","year":"2009","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbagen.2009.07.016_bib165","doi-asserted-by":"crossref","first-page":"14537","DOI":"10.1523\/JNEUROSCI.2692-08.2008","article-title":"Picomolar amyloid-beta positively modulates synaptic plasticity and memory in hippocampus","volume":"28","author":"Puzzo","year":"2008","journal-title":"J. Neurosci."},{"key":"10.1016\/j.bbagen.2009.07.016_bib166","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1101\/lm.1310209","article-title":"Amyloid beta mediates memory formation","volume":"16","author":"Garcia-Osta","year":"2009","journal-title":"Learn. Mem."},{"key":"10.1016\/j.bbagen.2009.07.016_bib167","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.neurobiolaging.2006.09.002","article-title":"Conversion from cognitive health to mild cognitive impairment and Alzheimer's disease: prediction by plasma amyloid beta 42, medial temporal lobe atrophy and homocysteine","volume":"29","author":"Blasko","year":"2008","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.bbagen.2009.07.016_bib168","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1212\/01.WNL.0000091890.32140.8F","article-title":"Plasma A[beta]40 and A[beta]42 and Alzheimer's disease: relation to age, mortality, and risk","volume":"61","author":"Mayeux","year":"2003","journal-title":"Neurology"},{"key":"10.1016\/j.bbagen.2009.07.016_bib169","doi-asserted-by":"crossref","first-page":"2405","DOI":"10.1074\/jbc.M505625200","article-title":"Down-regulation of endogenous amyloid precursor protein processing due to cellular aging","volume":"281","author":"Kern","year":"2006","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbagen.2009.07.016_bib170","doi-asserted-by":"crossref","first-page":"26326","DOI":"10.1074\/jbc.M611687200","article-title":"Partial reduction of BACE1 has dramatic effects on Alzheimer plaque and synaptic pathology in APP Transgenic Mice","volume":"282","author":"McConlogue","year":"2007","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbagen.2009.07.016_bib171","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1016\/S0002-9440(10)63159-8","article-title":"Beta-secretase activity increases with aging in human, monkey, and mouse brain","volume":"164","author":"Fukumoto","year":"2004","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.bbagen.2009.07.016_bib172","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/S0006-291X(02)02635-9","article-title":"alpha- and beta-secretase: profound changes in Alzheimer's disease","volume":"299","author":"Tyler","year":"2002","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.bbagen.2009.07.016_bib173","doi-asserted-by":"crossref","first-page":"6550","DOI":"10.1016\/j.febslet.2006.10.076","article-title":"Altered beta-secretase enzyme kinetics and levels of both BACE1 and BACE2 in the Alzheimer's disease brain","volume":"580","author":"Stockley","year":"2006","journal-title":"FEBS Lett."},{"key":"10.1016\/j.bbagen.2009.07.016_bib174","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1046\/j.1471-4159.1996.67020880.x","article-title":"Fate of cerebrospinal fluid-borne amyloid beta-peptide: rapid clearance into blood and appreciable accumulation by cerebral arteries","volume":"67","author":"Ghersi-Egea","year":"1996","journal-title":"J. Neurochem."},{"key":"10.1016\/j.bbagen.2009.07.016_bib175","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1172\/JCI10498","article-title":"Clearance of Alzheimer's amyloid-ss(1\u201340) peptide from brain by LDL receptor-related protein-1 at the blood\u2013brain barrier","volume":"106","author":"Shibata","year":"2000","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.bbagen.2009.07.016_bib176","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1038\/nm1635","article-title":"Clearance of amyloid-beta by circulating lipoprotein receptors","volume":"13","author":"Sagare","year":"2007","journal-title":"Nat. Med."},{"key":"10.1016\/j.bbagen.2009.07.016_bib177","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1097\/00008571-200210000-00005","article-title":"Deposition of Alzheimer's beta-amyloid is inversely correlated with P-glycoprotein expression in the brains of elderly non-demented humans","volume":"12","author":"Vogelgesang","year":"2002","journal-title":"Pharmacogenetics"},{"key":"10.1016\/j.bbagen.2009.07.016_bib178","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1038\/nm890","article-title":"RAGE mediates amyloid-beta peptide transport across the blood\u2013brain barrier and accumulation in brain","volume":"9","author":"Deane","year":"2003","journal-title":"Nat. Med."},{"key":"10.1016\/j.bbagen.2009.07.016_bib179","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1016\/S0896-6273(03)00787-6","article-title":"Enhanced proteolysis of beta-amyloid in APP transgenic mice prevents plaque formation, secondary pathology, and premature death","volume":"40","author":"Leissring","year":"2003","journal-title":"Neuron"},{"key":"10.1016\/j.bbagen.2009.07.016_bib180","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/j.nbd.2006.08.003","article-title":"Neuronal neprilysin overexpression is associated with attenuation of Abeta-related spatial memory deficit","volume":"24","author":"Poirier","year":"2006","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.bbagen.2009.07.016_bib181","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/j.neurobiolaging.2006.10.010","article-title":"Age-dependent decline of neprilysin in Alzheimer's disease and normal brain: inverse correlation with A beta levels","volume":"29","author":"Hellstrom-Lindahl","year":"2008","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.bbagen.2009.07.016_bib182","doi-asserted-by":"crossref","first-page":"6027","DOI":"10.1016\/j.febslet.2005.09.054","article-title":"Neprylisin decreases uniformly in Alzheimer's disease and in normal aging","volume":"579","author":"Russo","year":"2005","journal-title":"FEBS Lett."},{"key":"10.1016\/j.bbagen.2009.07.016_bib183","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1097\/01.jnen.0000240463.87886.9a","article-title":"Decreased expression and activity of neprilysin in Alzheimer disease are associated with cerebral amyloid angiopathy","volume":"65","author":"Miners","year":"2006","journal-title":"J. Neuropathol. Exp. Neurol."}],"container-title":["Biochimica et Biophysica Acta (BBA) - General Subjects"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304416509001986?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304416509001986?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,3,15]],"date-time":"2024-03-15T13:16:14Z","timestamp":1710508574000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0304416509001986"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,10]]},"references-count":183,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2009,10]]}},"alternative-id":["S0304416509001986"],"URL":"https:\/\/doi.org\/10.1016\/j.bbagen.2009.07.016","relation":{},"ISSN":["0304-4165"],"issn-type":[{"value":"0304-4165","type":"print"}],"subject":[],"published":{"date-parts":[[2009,10]]}}}